<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="8b57d46a-0737-4e2f-a1f4-da7ed20242d9"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Ann Richards</title>
  <effectiveTime value="20260512120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="5d6bdc10-4f81-44d1-b686-201efcc47323"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="506b0dcf-8826-427c-bb77-41df83196d99" extension="HR-ML019-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-19-3381"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Ann</given><family>Richards</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19620901"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260512120000-0500"/>
    <assignedAuthor><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260512120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="501d07ee-7c59-44a8-bdca-2087742b3903"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Three-month bone health review and first zoledronic acid infusion</originalText></code>
      <effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Three-month bone health review before the first zoledronic acid infusion. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Richards returns three months after intake. She has taken vitamin D3 2000 units every day and keeps her calcium at about 1200 mg a day from food. She collected the 24-hour urine sample over the weekend, and the result came back this morning with her blood tests. Her routine dental examination three weeks ago found no problems and no dental work is planned. She finished all 16 sessions of the balance and strength program four days ago and now does the home program three times a week. She has had no falls. She has had no alcohol. She has read about the infusion and asked about the flu-like reaction that can follow a first dose. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Vitamin D</td><td>D3 2000 units daily, no missed doses</td></tr><tr><td>Dental status</td><td>Routine examination three weeks ago; no work planned</td></tr><tr><td>Balance program</td><td>16 of 16 sessions; home program three times a week</td></tr><tr><td>Falls</td><td>None</td></tr><tr><td>Recovery</td><td>No alcohol; no cravings</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Musculoskeletal</td><td>Negative</td><td>No bone, back, or thigh pain</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>No kidney stones or urinary symptoms</td></tr><tr><td>Constitutional</td><td>Negative</td><td>No fever or recent illness; drinking plenty of fluid today</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; no cravings; no thoughts of self-harm</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Cholecalciferol (vitamin D3) 50 mcg (2000 units) oral tablet, one tablet daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2026-02-10</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Zoledronic acid 5 mg in 100 mL intravenous infusion over 30 minutes, once every 12 months</td><td>Once every 12 months, given in the clinic infusion room after a calcium and creatinine check</td><td>Intravenous route</td><td>2026-05-12</td><td>active</td><td>S</td></tr><tr ID="medication-3"><td>Acetaminophen 500 mg oral tablet, two tablets every 6 hours as needed for aches or fever for up to three days after the infusion (no more than 3 g a day)</td><td>Two tablets every 6 hours as needed for up to three days after the infusion</td><td>Oral route</td><td>2026-05-12 to 2026-05-15</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b3481bb1-4133-4482-9364-16739841a3b2"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260210"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="ug"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="801663" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.05 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="68a3690f-5947-4107-b3fd-b6d93cb5b1e5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ffd5927e-4ae6-405d-97a9-e74ffcaac69e"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260512"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="52" unit="wk"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="5" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="705824" codeSystem="2.16.840.1.113883.6.88" displayName="100 ML zoledronic acid 0.05 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="2dae606c-f500-44dd-8b16-ab7815fb608f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="645f8890-514b-4804-b1db-b5c0f165d299"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260512"/><high value="20260515"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ef514176-78b9-4272-8a6a-42a20422e5b2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="a46d5582-f4d8-49a6-8915-6c427800004e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="c50b1d31-806f-4e45-968b-a9567c93cc7e"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>2026-05-12</td><td>Body height</td><td>164</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>2026-05-12</td><td>Body weight</td><td>66.4</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>2026-05-12</td><td>Body mass index (BMI) [Ratio]</td><td>24.7</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>2026-05-12</td><td>Systolic blood pressure</td><td>120</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>2026-05-12</td><td>Diastolic blood pressure</td><td>74</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>2026-05-12</td><td>Heart rate</td><td>72</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>2026-05-12</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>2026-05-12</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>2026-05-12</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>99</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="72ec743a-5406-4320-9781-7dcc3e12f148"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260512"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5d3d9780-f92c-4c68-a71e-a601efcaa3f9"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="164" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5a953e1c-a6ad-4025-bbd6-899a5c4832fe"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="66.4" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="6d326dab-4e86-4b8b-be1c-64c973e32467"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="24.7" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="3a36c6f3-2df0-43b1-bc77-e6d8207ed2d2"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="120" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f72f0194-d677-4711-8e37-c76a68e5e7a7"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="74" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c06faf8e-8f28-49cc-b425-a51cd73b788c"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="72" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a6c82d26-ec2d-4ddd-942a-186045de0707"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a2417d7c-9c14-4c80-9cea-365a87239129"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5123971f-a915-438f-b24b-4c5e4ccf5258"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="20260512"/><value xsi:type="PQ" value="99" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-21"><td>2026-05-12</td><td>25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma</td><td>38</td><td>ng/mL</td><td>Target 30 ng/mL or higher before and during osteoporosis treatment</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-22"><td>2026-05-12</td><td>Calcium [Mass/volume] in Serum or Plasma</td><td>9.5</td><td>mg/dL</td><td>8.6-10.3 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-23"><td>2026-05-12</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>0.8</td><td>mg/dL</td><td>0.5-1 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-24"><td>2026-05-12</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>81</td><td>mL/min/{1.73_m2}</td><td>&gt;=60 mL/min/1.73 m²</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-25"><td>2026-05-12</td><td>Calcium [Mass/time] in 24 hour Urine</td><td>172</td><td>mg/(24.h)</td><td>100-300 mg/(24.h)</td><td>Normal</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="f2f03922-255e-4da8-8ccd-d029af0d8f03"/>
      <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="c4324e7e-3fe4-4fbb-8062-6f8932f1ae58"/>
          <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260512"/>
          <value xsi:type="PQ" value="38" unit="ng/mL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Target 30 ng/mL or higher before and during osteoporosis treatment</text>
              <value xsi:type="IVL_PQ"><low value="30" unit="ng/mL"/><high value="100" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="8b305d15-0c60-4f15-8890-ab023eae9552"/>
      <code code="17861-6" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="46bc4bc7-302d-43b7-828f-95699dde1794"/>
          <code code="17861-6" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-22"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260512"/>
          <value xsi:type="PQ" value="9.5" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>8.6-10.3 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="8.6" unit="mg/dL"/><high value="10.3" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="bd716703-ca0b-4b69-8a07-ba69c8412dd0"/>
      <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="973f645b-0ef4-475c-b4d1-2bc3f7ee2ff7"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-23"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260512"/>
          <value xsi:type="PQ" value="0.8" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.5-1 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.5" unit="mg/dL"/><high value="1" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="d4652950-3f0a-4555-8756-d71f0ec74f37"/>
      <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0bf057d3-2937-4655-a0dd-c20651b39f1e"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-24"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260512"/>
          <value xsi:type="PQ" value="81" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=60 mL/min/1.73 m²</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="2abdf7d0-95db-466b-88fc-4cd637ed8502"/>
      <code code="6874-2" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/time] in 24 hour Urine"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260512"/><high value="20260512"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="6b3046c0-b652-48c2-ae82-77396c92fabd"/>
          <code code="6874-2" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/time] in 24 hour Urine"/>
          <text><reference value="#result-25"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260512"/>
          <value xsi:type="PQ" value="172" unit="mg/(24.h)"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>100-300 mg/(24.h)</text>
              <value xsi:type="IVL_PQ"><low value="100" unit="mg/(24.h)"/><high value="300" unit="mg/(24.h)"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-05-12; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 66.4 kg</td></tr><tr><td>Mouth</td><td>Good dentition; no exposed bone</td></tr><tr><td>Gait and balance</td><td>Timed Up and Go 9 seconds; tandem stance 18 seconds</td></tr><tr><td>Spine</td><td>No tenderness or kyphosis</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 2020 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold)</td><td>active</td><td>confirmed</td>
    <td>M85.89</td><td>S — Synthetic modern DXA and FRAX classification linked to her publicly described osteopenia (early osteoporosis) after a fall with a hand fracture.</td>
  </tr>
  <tr ID="problem-2">
    <td>Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol since</td><td>active</td><td>confirmed</td>
    <td>F10.21</td><td>S — Synthetic modern coding of her publicly described heavy drinking and long recovery; listed because remission protects bone and lowers fall risk, and it is reviewed at each visit.</td>
  </tr>
  <tr ID="problem-3">
    <td>History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls since</td><td>active</td><td>confirmed</td>
    <td>Z91.81</td><td>S — Synthetic modern entry linked to her publicly described falls and fractures.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="3e4468da-c7a1-4a5b-9d7e-92485cb0fbee"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="f9a4786a-c379-402a-a1b3-dc944c3d8b13"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="6a39b65e-8a2b-44af-8bf2-8040ec7f2349"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="79fbf84c-4f8b-458c-9d06-ec4de2c182ef"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="F10.21" codeSystem="2.16.840.1.113883.6.90" displayName="Alcohol dependence, in remission"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="94dea7d6-a8ef-4956-b472-59214b08f6e1"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="f3e52ce3-3e17-458c-b860-f70f98c24306"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="Z91.81" codeSystem="2.16.840.1.113883.6.90" displayName="History of falling"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Low bone mass with high fracture risk by FRAX, starting treatment (M85.89)</content>. 25-hydroxyvitamin D 38 ng/mL, now at target. Calcium 9.5 mg/dL, creatinine 0.8 mg/dL, eGFR 81, and 24-hour urine calcium 172 mg, all normal, so the secondary-causes work-up is complete and shows no cause. Dental examination done. Ready for the first dose. [S]<list><item>Zoledronic acid 5 mg intravenously over 30 minutes in the infusion room today, after a glass of water.</item><item>Acetaminophen 1000 mg every 6 hours as needed for up to three days for the aches or fever that can follow a first dose.</item><item>Continue vitamin D3 2000 units daily and calcium from food.</item><item>Fasting morning CTX and calcium at the six-month visit.</item></list></item><item><content styleCode="Bold">History of falls (Z91.81)</content>. Balance much improved after the program: tandem stance 18 seconds, up from 8; Timed Up and Go 9 seconds, down from 11; no falls. [S]<list><item>Home balance and strength program three times a week.</item></list></item><item><content styleCode="Bold">Alcohol use disorder in sustained remission (F10.21)</content>. No alcohol or cravings. Safety reviewed: no thoughts of suicide or self-harm; the 988 Suicide &amp; Crisis Lifeline is saved in her phone. [S]<list><item>Continue the recovery check at each visit.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>25-hydroxyvitamin D</td><td>At baseline; after repletion until 30 ng/mL or more; then yearly</td><td>Completed today</td><td>38 ng/mL, up from 24; at target; next yearly</td></tr><tr><td>Laboratory</td><td>Serum calcium before each intravenous antiresorptive dose</td><td>Before each zoledronic acid dose</td><td>Completed today</td><td>9.5 mg/dL, normal; infusion given</td></tr><tr><td>Laboratory</td><td>Creatinine and eGFR before each zoledronic acid dose</td><td>Before each dose; do not give if creatinine clearance is below 35 mL/min</td><td>Completed today</td><td>Creatinine 0.8 mg/dL, eGFR 81</td></tr><tr><td>Laboratory</td><td>24-hour urine calcium</td><td>At diagnosis, before starting therapy</td><td>Completed today</td><td>172 mg in 24 hours, normal; no hypercalciuria. Deviation: collected about three months after it was ordered, because the sample was missed before the four-week visit. No harm resulted: no drug was started until it was done, and the result is normal. Corrective action: baseline tests that need a home collection are now scheduled with the patient before she leaves the intake visit</td></tr><tr><td>Laboratory</td><td>Bone-turnover marker (fasting serum CTX)</td><td>Baseline, then 3 to 6 months after starting or changing therapy</td><td>Due</td><td>Baseline 560 pg/mL; repeat at the six-month visit, three months after today&apos;s dose</td></tr><tr><td>Medication safety</td><td>Dental examination before an antiresorptive</td><td>Before starting a bisphosphonate or denosumab</td><td>Completed today</td><td>Routine examination three weeks ago with no problems; no invasive dental work planned</td></tr><tr><td>Medication safety</td><td>First zoledronic acid dose</td><td>Yearly</td><td>Completed today</td><td>5 mg intravenously over 30 minutes; acetaminophen plan given for the acute-phase reaction</td></tr><tr><td>Imaging</td><td>Central DXA of the spine and hip</td><td>Every 1 to 2 years on therapy until stable, on the same scanner</td><td>Up to date</td><td>Repeat two years after starting therapy</td></tr><tr><td>Examination</td><td>Standing height by stadiometer</td><td>Yearly; vertebral imaging again if height falls 2 cm or more</td><td>Up to date</td><td>164.0 cm at intake; unchanged on today&apos;s vital signs</td></tr><tr><td>Examination</td><td>Fall-risk screen</td><td>Yearly, and with any fall</td><td>Completed today</td><td>After the balance program: Timed Up and Go 9 seconds, tandem stance 18 seconds; no falls</td></tr><tr><td>Survey</td><td>Calcium intake assessment</td><td>At baseline and yearly</td><td>Up to date</td><td>About 1200 mg a day from food</td></tr><tr><td>Medication safety</td><td>Drug-holiday eligibility</td><td>After 3 yearly zoledronic acid doses or 5 years of an oral bisphosphonate</td><td>Not indicated</td><td>First dose today; reassess after the third yearly dose</td></tr><tr><td>Self-management</td><td>Balance and strength exercise program</td><td>With a history of falls or impaired balance</td><td>Completed today</td><td>16 of 16 sessions finished four days ago; home program three times a week</td></tr><tr><td>Self-management</td><td>Recovery check (alcohol, cravings, stress)</td><td>Every visit</td><td>Completed today</td><td>No alcohol; no cravings</td></tr><tr><td>Survey</td><td>Suicide-risk review and safety plan, with the 988 Suicide &amp; Crisis Lifeline</td><td>Every visit</td><td>Completed today</td><td>No thoughts of suicide or self-harm; the 988 Suicide &amp; Crisis Lifeline is saved in her phone</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Total calcium intake of about 1200 mg a day, mostly from food, by the four-week visit. Outcome by 2026-03-10: About 1200 mg a day from food by her own three-day food record [S]</item><item>25-hydroxyvitamin D of 30 ng/mL or more before the first infusion. Outcome by 2026-05-12: 24 ng/mL at intake and 38 ng/mL at three months [S]</item><item>First zoledronic acid dose by the three-month visit, with normal calcium and kidney function and a dental check done. Outcome by 2026-05-12: Given at three months after normal calcium (9.5 mg/dL) and eGFR (81) and a routine dental examination [S]</item><item>Complete the eight-week balance and strength program, with no falls through six months. In progress; target 2026-08-11 [S]</item><item>Serum CTX at least 30 percent lower three months after the first dose. In progress; target 2026-08-11 [S]</item><item>Sustained remission from alcohol use disorder throughout the episode. In progress; target 2026-08-11 [S]</item></list><paragraph>Guideline basis: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); The clinician&apos;s guide to prevention and treatment of osteoporosis (2022); American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update (2020); Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)</paragraph><paragraph>Follow-up: Zoledronic acid infusion today. Call the clinic for fever lasting more than three days, muscle cramps or tingling, or jaw pain. Six-month bone health review in three months with fasting CTX and calcium. Next scheduled visit 2026-08-11: six-month bone health review, three months after the first infusion. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
